Vanguard Group Inc Aclaris Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,515,458 shares of ACRS stock, worth $16.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,515,458
Previous 6,662,063 2.2%
Holding current value
$16.4 Million
Previous $9.46 Million 30.86%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$1.41 - $2.13 $206,713 - $312,268
-146,605 Reduced 2.2%
6,515,458 $12.4 Million
Q2 2025

Aug 11, 2025
BUY
$1.08 - $1.63 $1.83 Million - $2.76 Million
1,691,809 Added 34.04%
6,662,063 $9.46 Million
Q1 2025

May 09, 2025
BUY
$1.53 - $2.6 $986,836 - $1.68 Million
644,991 Added 14.91%
4,970,254 $7.6 Million
Q4 2024

Feb 11, 2025
SELL
$1.15 - $4.59 $414,270 - $1.65 Million
-360,235 Reduced 7.69%
4,325,263 $10.7 Million
Q3 2024

Nov 13, 2024
SELL
$1.12 - $1.4 $2,299 - $2,874
-2,053 Reduced 0.04%
4,685,498 $5.29 Million
Q2 2024

Aug 13, 2024
SELL
$1.01 - $1.36 $244,646 - $329,424
-242,224 Reduced 4.91%
4,687,551 $5.16 Million
Q1 2024

May 10, 2024
BUY
$0.92 - $1.44 $190,824 - $298,681
207,418 Added 4.39%
4,929,775 $6.11 Million
Q4 2023

Feb 14, 2024
BUY
$0.64 - $6.49 $869,959 - $8.82 Million
1,359,311 Added 40.42%
4,722,357 $4.96 Million
Q3 2023

Nov 14, 2023
BUY
$6.56 - $10.95 $219,641 - $366,627
33,482 Added 1.01%
3,363,046 $23 Million
Q2 2023

Aug 14, 2023
BUY
$7.89 - $10.64 $1.08 Million - $1.46 Million
137,138 Added 4.3%
3,329,564 $34.5 Million
Q1 2023

Jul 14, 2023
BUY
$7.07 - $17.95 $3,322 - $8,436
470 Added 0.01%
3,192,426 $25.8 Million
Q1 2023

May 15, 2023
BUY
$7.07 - $17.95 $492,786 - $1.25 Million
69,701 Added 2.23%
3,191,956 $25.8 Million
Q4 2022

Feb 10, 2023
BUY
$14.33 - $18.37 $2.73 Million - $3.5 Million
190,546 Added 6.5%
3,122,255 $49.2 Million
Q3 2022

Nov 14, 2022
BUY
$13.07 - $18.22 $1.54 Million - $2.15 Million
118,024 Added 4.19%
2,931,709 $46.1 Million
Q2 2022

Aug 12, 2022
BUY
$10.16 - $17.08 $862,228 - $1.45 Million
84,865 Added 3.11%
2,813,685 $39.3 Million
Q1 2022

May 13, 2022
BUY
$9.74 - $17.92 $104,344 - $191,976
10,713 Added 0.39%
2,728,820 $47 Million
Q4 2021

Feb 14, 2022
BUY
$12.27 - $18.49 $480,579 - $724,197
39,167 Added 1.46%
2,718,107 $39.5 Million
Q3 2021

Nov 12, 2021
BUY
$13.38 - $18.8 $1.5 Million - $2.11 Million
112,169 Added 4.37%
2,678,940 $48.2 Million
Q2 2021

Aug 13, 2021
BUY
$17.08 - $29.6 $43.8 Million - $76 Million
2,566,771 New
2,566,771 $45.1 Million

Others Institutions Holding ACRS

# of Institutions
104
Shares Held
81.7M
Call Options Held
0
Put Options Held
0
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $168M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email